Antihypertensives for pulmonary arterial hypertension
Bosentan
The FDA lists this product in 24 strengths and forms.
Composition
- Active ingredients
- BOSENTAN 125MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- BOSENTAN 125MG · TabletThis page
- BOSENTAN 62.5MG · TabletANDA205173-001 · Discontinued
- BOSENTAN 125MG · TabletANDA211461-002 · Discontinued
- BOSENTAN 62.5MG · TabletANDA211461-001 · Discontinued
- BOSENTAN 32MG · Tablet, for suspensionANDA213154-001 · Prescription
- BOSENTAN 62.5MG · TabletANDA207110-001 · Prescription
- BOSENTAN 125MG · TabletANDA207110-002 · Prescription
- BOSENTAN 125MG · TabletANDA210342-002 · Discontinued
- BOSENTAN 62.5MG · TabletANDA210342-001 · Discontinued
- BOSENTAN 62.5MG · TabletANDA205699-001 · Discontinued
- BOSENTAN 125MG · TabletANDA205699-002 · Discontinued
- BOSENTAN 125MG · TabletANDA209742-002 · Discontinued
- BOSENTAN 62.5MG · TabletANDA209742-001 · Discontinued
- BOSENTAN 32MG · Tablet, for suspensionANDA213981-001 · Prescription
At a glance
- Brand name
- Bosentan
- Drug class
- Antihypertensives for pulmonary arterial hypertension
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Mylan
- Status
- Discontinued
- FDA approval
- 15 Jan 2020
- Application
- ANDA205173-002
- RxCUI
- 75207